Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | -44.14K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EBITDA | -3.03M | -242.53K | -159.46K | -172.47K | -207.61K | -39.34K |
Net Income | -3.47M | -242.53K | -159.48K | -172.76K | -207.61K | -39.34K |
Balance Sheet | ||||||
Total Assets | 4.56M | 15.99K | 70.49K | 208.62K | 388.84K | 62.57K |
Cash, Cash Equivalents and Short-Term Investments | 287.31K | 4.77K | 48.21K | 200.35K | 363.65K | 62.57K |
Total Debt | 2.72M | 203.19K | 10.47K | 10.47K | 10.47K | 0.00 |
Total Liabilities | 6.67M | 247.40K | 59.37K | 38.02K | 45.48K | 38.27K |
Stockholders Equity | -2.11M | -231.41K | 11.13K | 170.60K | 343.36K | 24.30K |
Cash Flow | ||||||
Free Cash Flow | -1.71M | -236.17K | -152.14K | -163.30K | -236.06K | 0.00 |
Operating Cash Flow | -1.71M | -236.17K | -152.14K | -163.30K | -236.06K | 0.00 |
Investing Cash Flow | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Financing Cash Flow | 1.99M | 192.72K | 0.00 | 0.00 | 537.14K | 0.00 |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | £77.10B | 9.23 | 18.43% | 6.41% | -3.50% | -7.04% | |
73 Outperform | £1.54B | 20.22 | 15.70% | 0.27% | 31.84% | ― | |
63 Neutral | £35.60B | ― | -5.26% | 3.02% | -1.06% | -285.88% | |
54 Neutral | $23.42B | ― | -9.21% | 2.50% | -27.65% | -160.77% | |
44 Neutral | C$930.37M | -8.85 | -0.23% | 2.70% | 23.24% | -42.28% | |
31 Underperform | £5.54M | ― | ― | ― | ― |